Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.
about
Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancerPredictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Update on advances and controversy in rectal cancer treatment.Importance of surgical margins in rectal cancer.MRI for evaluation of treatment response in rectal cancer.Watch and Wait?--Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer.Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy.Oncological strategies for locally advanced rectal cancer with synchronous liver metastases, interval strategy versus rectum first strategy: a comparison of short-term outcomes.Pretreatment identification of patients likely to have pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer.Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.Chemoradiation and Local Excision for T2N0 Rectal Cancer Offers Equivalent Overall Survival Compared to Standard Resection: a National Cancer Database Analysis.Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation.Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes.Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer.The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer.Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients.Is long interval from neoadjuvant chemoradiotherapy to surgery optimal for rectal cancer in the era of intensity-modulated radiotherapy?: a prospective observational studyReport from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017
P2860
Q37156190-1DAC99EB-23E2-4B3A-936C-8098B33DC2E1Q37190172-C125DA00-EB1E-429F-AFEB-61F61A26563BQ37322728-02E77020-42A3-429C-90EB-E92045531D23Q37628506-C35F07D6-0692-44EF-8AF2-E7C5EFB5032CQ38594617-31F00D82-89E2-4F1A-83BB-848622E9A06BQ38692803-6DF4AA0E-3581-420A-9DC7-783CE743906EQ38812176-C99707CF-6C2E-46A2-9F9F-576E50501631Q38872993-8E4F31BA-0B87-40AF-8E16-868720ADF2DCQ38945257-358400F6-34CA-4636-96B5-6C904EFBC6FEQ38958169-A636CCD4-B8D7-4CCA-986F-3814BB4D15D6Q40531525-B18EB08D-9F55-48AE-B686-04FEABA0BDBBQ47255734-F9EDD874-B205-41E0-B27E-C2BDD0A8D776Q47299544-10BA9030-168C-4531-84F9-F9E747FFF805Q47755992-0F0A7D37-6321-4527-B8D5-03738A6DE31EQ47947401-086EC5E9-89FA-4FCD-B4AD-E92C60BC0D5DQ47978857-3D66B76C-B486-439B-B4B7-F8DEEDF3A23FQ48218127-3828632F-5FAF-44CC-B973-B4B7DD2F4D9DQ49564044-EE81C6FE-0569-4AA1-AC78-D013C2786AB9Q49633637-4511A29A-293C-449F-B270-42906FD2F028Q50066339-93FA98CE-9FD2-4136-82AA-EDDBB26C38C0Q51020379-3E43772E-0525-415B-AC1F-6A17AE0444D8Q55077052-5E48F42D-9FDC-4CAB-BF8E-1C4FC600AD57Q55331295-DECB12DB-170F-48E3-A32F-58E97ADB9272Q57071378-0CC7F43F-8238-43AA-9C22-01A41C24FDFEQ58783248-03A419D5-27AF-439B-A8B8-27F83BA35D3A
P2860
Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extended Intervals after Neoad ...... Potential Organ Preservation.
@en
Extended Intervals after Neoad ...... Potential Organ Preservation.
@nl
type
label
Extended Intervals after Neoad ...... Potential Organ Preservation.
@en
Extended Intervals after Neoad ...... Potential Organ Preservation.
@nl
prefLabel
Extended Intervals after Neoad ...... Potential Organ Preservation.
@en
Extended Intervals after Neoad ...... Potential Organ Preservation.
@nl
P2093
P2860
P1476
Extended Intervals after Neoad ...... d Potential Organ Preservation
@en
P2093
Adan Z Becerra
Christian P Probst
Consortium for Optimizing the Surgical Treatment of Rectal Cancer (OSTRiCh)
David W Dietz
Fergal J Fleming
Feza H Remzi
John R T Monson
Julio Garcia-Aguilar
Mohamedtaki A Tejani
Steven D Wexner
P2860
P304
P356
10.1016/J.JAMCOLLSURG.2015.04.010
P577
2015-04-23T00:00:00Z